A treatment for acute migraines has been approved for NHS use for the first time, with experts saying the move could be a “step-change” for thousands of people who suffer from the condition. The National Institute for Health and Care Excellence (Nice) said its final draft guidance on Rimegepant “addresses the high unmet need for treatment options for acute migraine”. Rimegepant, also known as Vydura and made by Pfizer, will be available to adults who have tried at least two triptans – medication usually given to tackle headaches or migraines – but found they did not work well enough. It can also be administered to those who are not able to take triptans or have an intolerance, or patients who have tried nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol. Helen Knight, director of medicines evaluation at Nice, said: “Migraine is a condition described in comments to Nice from carers and people with migraine as an invisible disability that affects all aspects of life including work, education, finances, mental health, social activities and family. “Today’s final draft guidance addresses the high unmet need for treatment options for acute migraine, once again demonstrating our ability to ensure clinically and cost-effective medicines are available to those who need them as quickly as possible.” Rimegepant is taken as a wafer, which dissolves under the tongue and works by stopping the release of a protein around the brain called calcitonin gene-related peptide. In July, the medicine was recommended as an option for preventing episodic migraines in adults who have at least four and fewer than 15 attacks per month if “at least” three other treatments have not worked. This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment Helen Knight, Nice Under the latest guidance, it will also be used to relieve symptoms of a migraine, which can include pain, nausea and sensitivity to light, but also painless symptoms such as temporary visual disturbances known as “aura”, which Nice said “is not well managed with existing treatments”. The recommendation is expected to benefit about 13,000 people. Ms Knight added: “This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment.” Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health Robert Music, The Migraine Trust Robert Music, chief executive of The Migraine Trust, said the Nice guidance “provides people with migraine valuable options to help reduce the pain and length of a migraine attack”. “It brings new hope,” he added. “It will especially benefit those who have not found a treatment that works, those who get debilitating side effects – including medicine overuse headache – from them, and those with cardiovascular disease who cannot take existing treatments. “Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health.” Read More NHS winter resilience fund announced by Government NHS reliance on paper notes ‘stopping trusts from realising full potential’ Recession fears as UK economy shrinks by more than expected in shock decline Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live

United States standout Christian Pulisic scored in his first match at San Siro to set the Rossoneri on their way to a 4-1 win over Torino in Serie A

European shares extended losses on Tuesday as a surge in U.S. Treasury yields and the dollar mounted pressure

The Colorado Buffaloes have lost a slew of commitments and their recruiting ranking is falling. Now Coach Prime is being linked to another Big 12 job.

Nordstrom beat expectations for quarterly revenue on Thursday, benefiting from steady demand from affluent shoppers at a time

A woman was charged in her newborn girl's death nearly 40 years after the abandoned baby was found dead in a remote wooded area in New Jersey, according to the Morris County Prosecutor's Office.

MLB Rumors: Could the St. Louis Cardinals deal some young talent to acquire pitching? Will Craig Counsell remain in Milwaukee or join Stearns with the Mets? Are Red Sox gearing up for big trades with their young pieces?

Lionel Messi keeps scoring goals, and Inter Miami keeps winning games

Jorginho reacts to Arsenal's pursuits of Declan Rice and Jurrien Timber and why the transfers still haven't gone through.

Andreas Maxsø scored in the 41st minute, Marko Ilic made five saves and the Colorado Rapids beat Austin 1-0 on Saturday night for just their fifth victory of the season

Algerian journalist Maher Mezahi writes about the riots that swept through France.

Bayer AG faces two fresh setbacks, causing the stock to plummet, after stopping the main study of its